SkinBioTherapeutics Plc carries a market capitalization of 22.03M, placing it among publicly traded companies globally.
| Market Cap | 22.03M |
| Enterprise Value | N/A |
SkinBioTherapeutics Plc's stock has declined approximately -50.72464% over the past 52 weeks. The 50-day moving average sits at 3.38, while the 200-day moving average is 11.79.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50.72464% |
| 50-Day Moving Average | 3.38 |
| 200-Day Moving Average | 11.79 |
| Average Volume (20 Days) | N/A |